(Date:5/15/2008)...ts Confirm Efficacy for Population Most Affected b...May 16 /-,Bayer HealthCare ...c.,(Nasdaq: ONXX ) today announced that Nexavar(R...ll survival by 47.3 percent (HR=0.68;,p-value=0.01...anced,hepatocellular carcinoma (HCC), or primary l...
(Date:5/15/2008)...Efficacy Clinical Data from Prostate, Colorectal a..., - Company to Hold Investor Event on Sun., June ...alif., May 15 /- Poniard,Ph...eutical company focused,on oncology, today announc...linical trials of picoplatin, in various tumor typ...
(Date:5/15/2008)... reductions demonstrated in Blacks, Hispanics/Lati...se Individuals, PARSIPPANY, N.J., May 15 /PRNewsw... data presented at the American Society of,Hyperte...SH 2008) in New,Orleans demonstrated that the powe...esartan medoxomil) safely and effectively helped,p...
(Date:5/15/2008)...y 15 /- CenterWatch, a publishing and...search about clinical,trials, finds that investiga...ctronic data capture) systems. More than 75% of re... that they had been trained on three or more,EDC s... effectiveness of,their EDC training had improved....
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers 26 Distribution Managers 9819 1Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers 26 Distribution Managers 9819 2Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers 26 Distribution Managers 9819 3Cardiome And Astellas Announce Regulatory Update 9815 1Cardiome And Astellas Announce Regulatory Update 9815 2Cardiome And Astellas Announce Regulatory Update 9815 3Cardiome And Astellas Announce Regulatory Update 9815 4Study looks at off label use of biliary stents 9812 1Study looks at off label use of biliary stents 9812 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 1NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 3NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 4NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 5... - Study shows orally-delivered GLP-1 is able to s...9, 2007 /PRNewswire-FirstCall/ --,Emisphere Techno...l,studies conducted in collaboration with Professo...rology and Hepatology,University Hospital Basel i...ith glucagon-like peptide-1 (7-36 amide) (GLP-1) w...
... SAN DIEGO--(BUSINESS WIRE)--Mar 29, 2007 - ACADIA...eutical company utilizing,innovative technology to...ovel treatments for central nervous system,disorde...at the,2007 International Congress on Schizophreni...07, in Colorado Springs, Colorado.,Presentations w...
Other Medicine Technology:Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 2Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 3Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 4Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 5ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 2ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 3ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 4ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 5(Date:5/16/2008)...ld benefit most from chemo after surgery, study sa...- A panel of 15 genes may help determine which pat...will experience a recurrence and, therefore, benef... , By extension, the same genetic signature may... of the cancer who would be able to forego chemoth...
(Date:5/16/2008)...- Huntsworth plc (LSE: HNT), "the Group",a leadin...mmunications,group headquartered in London, releas...he Group,s performance in the first quarter 2008 (...nt follows below., 15 May 2008, ...Interim Management Statement, Record n...
(Date:5/16/2008)...tudents learn the lesson of helping others ...ANJING, China, May 16 /PRNewswire/ -- In the after...he youngest members of China are,looking for ways ...ound the,country, schools are running donation dri...s principal, Ms. Zhang Lijun, the 190-student stro...
(Date:5/16/2008)...ops More in 2007, WASHINGTON, May 16 /PRNewswire-...ee cancer deaths, the National Cancer Institute (N...et in lung cancer research in 2007,according to u...LCA) today., The two other federal agencies with ...r Disease Control and Prevention (CDC) and the,Dep...
Breaking Medicine News(10 mins):Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:Lung Cancer Still Lowest in Federal Funding 2...the flexibility of polyaxial screws and the versat... The result is a construct that, during assembly, ...my, thus reducing potential for vertebral injury. ...nnectors reduces the potential for transferring lo...
...chnology in spinal instrumentation to treat a vari...umbar spine, spondylolisthesis, kyphosis, scoliosi...he treaent of severe spondylolisthesis (grades 3 a...ew fixation for this indication are from L3-S1. Wh...
Multiwindow transcranial and peripheral doppler system.
Transcranial & peripheral vascular doppler system.
Medicine Products: